Biomapas Logo
cropped-favicon-biomapas.png

Regulatory Strategy in the EAEU and rest of CIS Countries

Regulatory Strategy in the EAEU and rest of CIS Countries

Webinar: Regulatory Strategy in the EAEU and Rest of CIS Countries

Regulatory strategy in EAEU and CIS regions differ from other regions as market access to these countries can be a real challenge due to various local regulations. However, it is only a matter of experience and adequate know-how.

This webinar focuses on choosing your regulatory strategy for Eurasian Economic Union and Commonwealth of Independent States, best practices and practical tips for market access and current regulatory status and GMP requirements.

 

You will learn about:

1. Commonwealth of Independent States

  • Differences and overlaps with EAEU

2. Regulatory strategy in the EAEU

  • Current status and main challenges
  • Practical tips

3. Regulatory strategy in the CIS region

  • What is the current status?
  • Best practices and key tips for main challenges
  • GMP requirements in EAEU and CIS

 

Entering EAEU or CIS markets?

Make use of our experts’ know-how to access new markets. Explore your options in a chat with one of our experts.

Let's Talk

Who should attend?

  • Global and regional RA Managers
  • Regulatory Strategy Managers
  • RA Partnerships Operations Manager
  • QA Managers supporting RA
  • RA Healthcare Compliance Managers

Duration: 25 min.

Speaker: Regulatory Affairs Project Manager, Nargiz Asgarova, who will share her expertise on regulatory strategy in EAEU and CIS regions.

Nargiz Asgarova, BSc, MBA

Nargiz Asgarova, BSc, MBA

Regulatory Affairs Project Manager

Other content that might interest you:

Medical Device Registration in Russia. The Essentials

Medical Device Registration in Russia. The Essentials

Mar 17, 2021

Webinar: Successful Medical Device Registration in Russia. The Essentials The current national system for Medical Device registration in Russia was created from scratch and entered into force in 2013. Most experts agree that this system is complex and puzzling – some...

read more
Expediting access through Reliance Pathways: MENA region

Expediting access through Reliance Pathways: MENA region

Mar 16, 2021

Reliance models are review pathways used by Regulators to expedite the patient access to essential pharmaceutical products and to overcome resource constraints and priorities. Recently, several National Competent Authorities (NCA) in the Middle East North Africa (MENA) region have implemented the Abridged and Verification reviews. These regulatory procedures allow the approvement of needed innovative and/or life-saving drugs.

read more
Medical Device Registration in Russia. Challenges and Issues

Medical Device Registration in Russia. Challenges and Issues

Mar 15, 2021

Webinar: Medical Device Registration in Russia. Challenges and Issues The purpose of this webinar is to show the differences and specifics of regulations and law processes that can cause challenges in medical device registration in Russia.   You will learn about:...

read more
CMC: Best Practice in Effective IND and IMPD writing

CMC: Best Practice in Effective IND and IMPD writing

Previously, we have discussed the importance of dedicated team for CMC writing as well as project management aspects for effective IND/IMPD writing (previous text here). This time we will focus on technical writing and preparation for it. Also, I will provide some...

CMC: Effective Writing of IND and IMPD

CMC: Effective Writing of IND and IMPD

Do we truly know how to ensure IND or IMPD Quality (CMC) part is written in good quality, consistent and clear technical language? How to effectively manage the writing process? In this article, I will focus on these questions and the initial IND/IMPD, required to...

Biomapas appoints Head of Global Regulatory Affairs

Biomapas appoints Head of Global Regulatory Affairs

May 2020 – Olga Bernardova joins Biomapas as Head of Global Regulatory Affairs to lead the regulatory affairs department and to ensure the best processes and means to serve Biomapas growth and international expansion. As a functional and full outsourcing solution...

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.
Affiliate-Based Outsourcing
CSV For Pharmacovigilance Systems
Early Phase Oncology
Functional Service Provision
M&A Support

Clinical Research

Read more

Regulatory Affairs

Read more

Pharmacovigilance

Read more

Medical Information

Read more